Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Piperonyl butoxide (PBO) combined with pyrethroids in long‐lasting insecticidal nets (LLINs) to prevent malaria in Africa

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD012776Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 25 agosto 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Enfermedades infecciosas

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Katherine Gleavea

    Correspondencia a: Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK

    [email protected]

    These authors contributed equally to this work.

  • Natalie Lissendena

    Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK

    These authors contributed equally to this work.

  • Marty Richardson

    Cochrane Infectious Diseases Group, Liverpool School of Tropical Medicine, Liverpool, UK

  • Hilary Ranson

    Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK

Contributions of authors

KG, NL, and HR conceived and designed the protocol.
MR provided statistical input.
KG, NL, HR, and MR read and approved the final protocol draft.

Sources of support

Internal sources

  • Liverpool School of Tropical Medicine, UK.

External sources

  • Department for International Development, UK.

    Grant: 5242

  • World Health Organization (WHO), Switzerland.

    WHO Global Malaria Programme Agreement for Performance of Work (APW) Grant 2017 (number 709319)

Declarations of interest

KG has no known conflicts of interest.
NL has acted as rapporteur since 2015 for the Innovative Vector Control Consortium (IVCC) at their External Scientific Advisory Committee (ESAC) meetings.
MR has no known conflicts of interest.
HR has served on a WHO committee to consider the evidence for PBO nets in malaria control. Preparation of the background work presented at this WHO meeting was funded by the Global Fund for AIDS, TB and Malaria. Although HR interacts regularly with bednet manufacturers through her own research and her role on the IVCC's advisory panels, neither HR nor her research group have received direct funding from these companies.

Acknowledgements

We thank Vittoria Lutje, Cochrane Infectious Diseases Group (CIDG) Information Specialist, for her assistance in conducting the literature search and Paul Garner, CIDG Co‐ordinating Editor, for his guidance during the protocol preparation process.

This work was supported through a grant from the World Health Organization (WHO) Global Malaria Programme.

Marty Richardson is supported by the Effective Health Care Research Consortium. This Consortium and the CIDG editorial base are funded by UK aid from the UK Government for the benefit of developing countries (Grant: 5242). The views expressed in this review do not necessarily reflect UK government policy.

Version history

Published

Title

Stage

Authors

Version

2021 May 24

Piperonyl butoxide (PBO) combined with pyrethroids in insecticide‐treated nets to prevent malaria in Africa

Review

Katherine Gleave, Natalie Lissenden, Marty Chaplin, Leslie Choi, Hilary Ranson

https://doi.org/10.1002/14651858.CD012776.pub3

2018 Nov 29

Piperonyl butoxide (PBO) combined with pyrethroids in insecticide‐treated nets to prevent malaria in Africa

Review

Katherine Gleave, Natalie Lissenden, Marty Richardson, Leslie Choi, Hilary Ranson

https://doi.org/10.1002/14651858.CD012776.pub2

2017 Aug 25

Piperonyl butoxide (PBO) combined with pyrethroids in long‐lasting insecticidal nets (LLINs) to prevent malaria in Africa

Protocol

Katherine Gleave, Natalie Lissenden, Marty Richardson, Hilary Ranson

https://doi.org/10.1002/14651858.CD012776

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Table 1. WHOPES classification

WHOPES Phase

Definition

WHOPES Phase I. Laboratory bioassays

Cone bioassays: these are studies that are conducted in the laboratory setting and use standard WHO protocols (WHOPES 2013, Section 2.2.1), where mosquitoes are exposed to a suitable LLIN (treated intervention or untreated control) for three minutes using a standard plastic WHO cone. Following net exposure, mosquitoes are transferred to a holding container and maintained on a sugar solution diet while entomological outcomes (mosquitoes knocked down one hour post‐exposure, and mosquito mortality 24 hours post‐exposure) are measured.

Tunnel tests: these are studies conducted in the laboratory setting that use standard WHO protocols (WHOPES 2013, Section 2.2.2). Mosquitoes are released into a glass tunnel covered at each end with untreated netting. The intervention or control LLIN net sample is placed one‐third down the length of the tunnel and the net contains nine holes that enable mosquitoes to pass through. A suitable bait is immobilized in the shorter section of the tunnel where it is available for mosquito biting. Mosquitoes are released into the opposite end of the tunnel and must make contact with the net and locate holes before being able to feed on the bait. After 12 to 15 hours, mosquitoes are removed from both sections of the tunnel and entomological outcomes (the number of mosquitoes in each section, mortality, and blood‐feeding inhibition at the end of the assay and 24 hours post‐exposure) are recorded.

Wire‐ball bioassays: these are studies conducted in the laboratory setting where mosquitoes are introduced into a wire‐ball frame that has been covered with either the intervention or control LLIN. Mosquitoes are exposed for three minutes, after which they are transferred to a holding container and entomological outcomes (mosquitoes knocked down one hour post‐exposure, and mosquito mortality 24 hours post‐exposure) are measured.

WHOPES Phase II. Experimental hut trials

WHOPES Phase II experimental hut trials are field trial studies conducted in Africa where wild mosquito populations or local colonized populations are evaluated. Volunteers or livestock sleep in experimental huts under a purposefully holed LLIN, with one person or animal per hut. Huts are designed to resemble local housing based on a West or East African design (WHOPES 2013; Section 3.3.1‐2). However they have identical design features, such as eave gaps or entry slits to allow mosquitoes to enter, and exit traps to capture exiting mosquitoes. LLINs and volunteers are randomly allocated to huts and rotated in a Latin square to avoid bias, with huts cleaned between rotations to avoid contamination. Several nets, including an untreated control net, can be tested at the same time. Dead and alive mosquitoes are collected each morning from inside the net, inside the hut, and inside the exit traps. They are then scored as either blood‐fed or non‐blood‐fed, and either alive or dead, and live mosquitoes are maintained for a further 24 hours to assess delayed mosquito mortality.

WHOPES Phase III. Village trials

WHOPES Phase III village trials are village trials conducted in Africa where wild mosquito populations are evaluated. Villages chosen to be included in the study are similar in terms of size, housing structure, location, and the data available on the insecticide resistance status of the local malaria vectors. Households are assigned either conventional LLINs or PBO‐LLINs. Randomization can be at the household or village level. Adult mosquitoes are collected from the study houses and mosquito density is measured. An indication of malaria transmission is measured in the study sites either by recording infections in mosquitoes, malaria prevalence, or malaria incidence.

Figuras y tablas -
Table 1. WHOPES classification
Table 2. WHO‐recommended LLINs

Product name

Product type

Status of WHO recommendation

DawaPlus 2.0

Deltamethrin coated on polyester

Interim

DawaPlus 3.0

Combination of deltamethrin coated onto polyester (side panels), and deltamethrin and PBO incorporated into polyester (roof)

Interim

DawaPlus 4.0

Deltamethrin and PBO incorporated into polyester

Interim

Duranet

Alpha‐cypermethrin incorporated into polyethylene

Full

Interceptor

Alpha‐cypermethrin coated on polyester

Full

LifeNet

Deltamethrin incorporated into polypropylene

Interim

MAGNet

Alpha‐cypermethrin incorporated into polyethylene

Full

MiraNet

Alpha‐cypermethrin incorporated into polyethylene

Interim

Olyset Net

Permethrin incorporated into polyethylene

Full

Olyset Plus

Permethrin and PBO incorporated into polyethylene

Interim

Panda Net 2.0

Deltamethrin incorporated into polyethylene

Interim

PermaNet 2.0

Deltamethrin coated on polyester

Full

PermaNet 3.0

Combination of deltamethrin coated on polyester with strengthened border (side panels), and deltamethrin and PBO incorporated into polyethylene (roof)

Interim

Royal Sentry

Alpha‐cypermethrin incorporated into polyethylene

Full

SafeNet

Alpha‐cypermethrin coated on polyester

Full

Veeralin

Alpha‐cypermethrin and PBO incorporated into polyethylene

Interim

Yahe

Deltamethrin coated on polyester

Interim

Yorkool

Deltamethrin coated on polyester

Full

Abbreviations: LLIN: long‐lasting insecticidal net; WHO: World Health Organization.

Figuras y tablas -
Table 2. WHO‐recommended LLINs
Table 3. WHO‐recommended insecticide products for treatment of mosquito nets for malaria vector control

Insecticide

Formulation1

Dosage2

Alpha‐cypermethrin

SC 10%

20 to 40

Cyfluthrin

EW 5%

50

Deltamethrin

SC 1%
WT 25%
WT 25% + binder3

15 to 25

Etofenprox

EW 10%

200

Lambda‐cyhalothrin

CS 2.5%

10 to 15

Permethrin

EC 10%

200 to 500

1Abbreviations: EC: emulsifiable concentrate; EW: emulsion, oil in water; CS: capsule suspension; SC: suspension concentrate; WT: water dispersible tablet.
2Active ingredient/netting (mg/m²).
3K‐O TAB 1‐2‐3.

Figuras y tablas -
Table 3. WHO‐recommended insecticide products for treatment of mosquito nets for malaria vector control
Table 4. Definition of resistance level

Outcome

Confirmed resistance

Suspected resistance

Susceptible

Unclassified

WHO mosquito mortality

< 90%

90% to 97 %

98% to 100%

Unknown

CDC knock‐down

< 90%

80% to 97%

98% to 100%

Unknown

Abbreviations: CDC: Centers for Disease Control and Prevention; WHO: World Health Organization.

Definition of resistance level based on mosquito mortality (%) after exposure to insecticide in a WHO diagnostic dose assay (WHO mosquito mortality), or a CDC bottle bioassay (CDC knock‐down) using the methodology, diagnostic doses, and diagnostic times recommended by each test respectively.

Figuras y tablas -
Table 4. Definition of resistance level
Table 5. Stratification of resistance level

Outcome

Low

Moderate

High

Unclassified

Mosquito mortality1

61% to 90%

31% to 60%

< 30%

Unknown

124‐hour post‐exposure mortality (%).

Figuras y tablas -
Table 5. Stratification of resistance level
Table 6. Study inclusion screening form

Criteria

Assessment

Comments

Yes

No

Unclear

Mosquito population

Did the study test Anopheles gambiae complex or Anopheles funestus group mosquitoes?

State mosquito species

Were a minimum of 50 mosquitoes tested per study arm?

Intervention

Did the study include an long‐lasting insecticidal net (LLIN) or insecticide treated net (ITN)?

State net LLIN or ITN

Was the intervention net either of the following?

  • A piperonyl butoxide (PBO) LLIN which received a minimum of interim World Health Organization (WHO) approval.

  • An ITN impregnated with WHO‐recommended dose of pyrethroid + PBO.

State net type

Was the control net either of the following?

  • A pyrethroid LLIN of the same fabric impregnated with the same insecticide and dose as intervention net (objective 1).

  • A pyrethroid LLIN impregnated with the same insecticide at any dose (objective 2 (a and b)).

State which objective study meets

Study design

Was the study one of the following?

  • Laboratory bioassay (cone, tunnel, ball)

  • Experimental hut study

  • Village trial

State study type

For laboratory bioassay. Did the study use standard‐WHO protocol?

For experimental hut study and village trial. Was the study conducted in Africa?

State country

Outcome

Did the study include at least one of the following outcome measures?

  • Mortality.

  • Blood feeding.

  • Sporozoite rate.

  • Not passed through net.

  • Deterrence.

  • Exophily.

  • Mosquito density.

  • Parity rate.

Decision

Is the study eligible for inclusion?

State reason(s) for exclusion

Discuss with authors

Figuras y tablas -
Table 6. Study inclusion screening form